

Health Library
October 10, 2025
Question on this topic? Get an instant answer from August.
I-Trastuzumab-dkst iyimithi yomdlavuza eqondiswe ngqo esiza ukulwa nezinhlobo ezithile zomdlavuza wamabele nesifo somdlavuza wesisu. Yilokho odokotela abakubiza ngokuthi "i-biosimilar" ku-trastuzumab yasekuqaleni (Herceptin), okusho ukuthi isebenza ngendlela efanayo kodwa yenziwa ngumkhiqizi ohlukile.
Le mithi iqondise ngqo amaseli omdlavuza anenani elikhulu lephrotheni ebizwa nge-HER2. Cabanga ngayo njenge-missile eqondisiwe efuna futhi ihlasele amaseli omdlavuza kuphela anale nhloso ethile, kuyilapho ishiya amaseli akho anempilo yedwa.
I-Trastuzumab-dkst iphatha umdlavuza wamabele we-HER2-positive kanye nomdlavuza wesisu we-HER2-positive. Udokotela wakho uzohlola izicubu zakho zomdlavuza ukuze aqinisekise ukuthi zinamazinga aphezulu eprotheni ye-HER2 ngaphambi kokubhala le mithi.
Ngomdlavuza wamabele, ingasetshenziswa ezimweni ezihlukene. Ngezikhathi ezithile inikezwa ngemva kokuhlinzwa ukuvimbela umdlavuza ukuthi ungabuyi. Ngezikhathi ezithile, isetshenziswa uma umdlavuza usabalale kwezinye izingxenye zomzimba wakho.
Ezimweni zomdlavuza wesisu, ngokuvamile ihlanganiswa ne-chemotherapy uma umdlavuza usabalale noma ungenakususwa ngokuhlinzwa. Imithi isiza ukunciphisa ukukhula komdlavuza futhi ingakusiza ukuthi uphile isikhathi eside ngekhwalithi yempilo engcono.
I-Trastuzumab-dkst isebenza ngokuvimba iprotheni ye-HER2 kumaseli omdlavuza. Uma i-HER2 isebenza ngokweqile, itshela amaseli omdlavuza ukuthi akhule futhi ahlukaniswe ngokushesha.
Le mithi isebenza njengokhiye kulowo protheni, ivimbela ukuthi ingathumeli izimpawu zokukhula kumaseli omdlavuza. Lokhu kusiza ukunciphisa noma ukumisa umdlavuza ekukhuleni nasekusabalaleni.
Kuthathwa njengokwelashwa komdlavuza okunamandla ngokulinganisela okuvame ukubekezeleleka kahle uma kuqhathaniswa ne-chemotherapy yendabuko. Abantu abaningi bangagcina imisebenzi yabo yansuku zonke ngenkathi bethola lokhu kwelashwa, nakuba uzodinga ukuqapha njalo.
I-Trastuzumab-dkst inikezwa njenge-IV infusion ngokuqondile emgudwini wakho wegazi esibhedlela noma esikhungweni somdlavuza. Awukwazi ukuthatha lo muthi ekhaya ngamaphilisi noma ngemijovo.
I-infusion yakho yokuqala izothatha imizuzu engaba ngu-90, kuyilapho ukwelashwa okulandelayo kuvame ukuthatha imizuzu engaba ngu-30. Uzoyithola masonto onke noma njalo emavikini amathathu, kuye ngohlelo lwakho oluqondile lokwelashwa.
Ngaphambi kwe-infusion ngayinye, cishe uzothola imithi yokuvimbela ukusabela komzimba. Akudingeki ukuthi ugweme ukudla ngaphambi kokwelashwa, kodwa ukuhlala unamanzi ngokwanele ngokuphuza amanzi amaningi kungakusiza ukuthi uzizwe ungcono ngesikhathi nangemva kwe-infusion.
Ubude bokwelashwa buhlukahluka kakhulu ngokuya ngesimo sakho esiqondile. Ngomdlavuza webele wesigaba sokuqala, ukwelashwa kuvame ukuthatha unyaka owodwa (amasonto angu-52) ngemva kokuhlinzwa kanye ne-chemotherapy.
Ngomdlavuza othuthukile noma ometastatic, ungaqhubeka nokwelashwa uma nje kusebenza futhi ukubekezelela kahle. Abanye abantu bayayithola izinyanga eziningi noma iminyaka.
Udokotela wakho we-oncologist uzohlola njalo ukuthi ukwelashwa kusebenza kahle kangakanani ngokuskena, ukuhlolwa kwegazi, kanye nokuhlolwa komzimba. Bazolungisa uhlelo lwakho lokwelashwa ngokusekelwe ekutheni umdlavuza wakho usabela kanjani nokuthi uzizwa kanjani.
Abantu abaningi bahlangabezana nemiphumela ethile engemihle, kodwa ngokuvamile iyaphathwa futhi ayibi kangako kunemiphumela engemihle ye-chemotherapy yendabuko. Ake sihambe ngalokho ongakulindela, siqale ngamava avamile kakhulu.
Imiphumela ejwayelekile ongase uyibone ihlanganisa:
Lezi zimpawu ziyindlela yomzimba wakho yokujwayela imithi, futhi abantu abaningi bathola ukuthi ziyathuthuka ngokuhamba kwesikhathi. Ithimba lakho lezempilo lingase linikeze izindlela zokuphatha lezi zimo ukuze uzizwe ukhululekile.
Imiphumela emibi engathi sína edinga ukunakekelwa ngokushesha ihlanganisa:
Ngenkathi le miphumela emibi ingavamile, ithimba lakho lezokwelapha lizokuqapha ngokucophelela futhi lihlole ukusebenza kwenhliziyo yakho njalo. Abantu abaningi baqeda ukwelashwa kwabo ngaphandle kwezinkinga ezinkulu.
I-Trastuzumab-dkst ayifanele wonke umuntu, futhi udokotela wakho uzohlola ngokucophelela ukuthi ilungele yini wena. Okukhathaza kakhulu ukuqinisekisa ukuthi inhliziyo yakho iphilile ngokwanele ngale ndlela yokwelapha.
Akufanele uthole lo muthi uma unezinkinga zenhliziyo ezinzima, okuhlanganisa ukuhluleka kwenhliziyo noma ukuncipha okukhulu kokusebenza kwenhliziyo. Udokotela wakho uzohlola inhliziyo yakho ngezivivinyo ezinjenge-echocardiogram ngaphambi kokuqala ukwelashwa.
Abantu abanezifo eziqhubekayo, ezinzima kufanele balinde kuze kube yilapho ukutheleleka kuphela ngaphambi kokuqala ukwelashwa. Uma ukhulelwe noma uhlela ukukhulelwa, lo muthi ungalimaza ingane yakho esakhula, ngakho-ke uzodinga ukusebenzisa izindlela zokulawula inzalo eziphumelelayo ngesikhathi sokwelashwa kanye nezinyanga eziyisikhombisa ngemuva komthamo wakho wokugcina.
Udokotela wakho uzobuye acabangele impilo yakho yonke, eminye imithi oyithathayo, kanye nanoma yimuphi umlando wezinkinga zamaphaphu ngaphambi kokuncoma lokhu kwelashwa.
I-Trastuzumab-dkst ithengiswa ngaphansi kwegama lomkhiqizo elithi Ogivri. Yenziwa yi-Mylan Pharmaceuticals futhi yavunywa njenge-biosimilar ye-Herceptin yasekuqaleni.
Ama-Biosimilars afana ne-Ogivri asebenza ngendlela efanayo njengomuthi wokuqala kodwa angase abe ngabiza kancane. Umshwalense wakho ungase ukhethe inguqulo ye-biosimilar, futhi udokotela wakho angakusiza ukuthi uqonde ukuthi iyiphi inketho engcono kakhulu esimweni sakho.
Eminye imithi eminingi iqondise iminyango ye-HER2-positive, ngalinye linokwalo ukuzuzisa. I-trastuzumab yasekuqaleni (Herceptin) isebenza ngokufana ne-trastuzumab-dkst futhi ivame ukushintshana.
Ezinye izinketho ezihloselwe i-HER2 zihlanganisa i-pertuzumab (Perjeta), evame ukuhlanganiswa ne-trastuzumab ukuze kube nomphumela oqinile, kanye ne-T-DM1 (Kadcyla), ehlanganisa i-trastuzumab ne-chemotherapy emuthini owodwa.
Izinketho ezintsha njenge-tucatinib (Tukysa) kanye ne-neratinib (Nerlynx) zisebenza ngendlela ehlukile ngokuvimba i-HER2 ngaphakathi kweseli lomdlavuza. Udokotela wakho we-oncologist uzokhetha inketho engcono kakhulu ngokusekelwe ohlotsheni lomdlavuza wakho oluthile, ukwelashwa kwangaphambilini, nempilo yakho yonke.
I-Trastuzumab-dkst (Ogivri) kanye ne-Herceptin zisebenza ngendlela efanayo futhi zinezinto ezifanayo zokusebenza kahle nemiphumela emibi. Izifundo zemitholampilo zibonisa ukuthi zilungile ngokulinganayo ekwelapheni iminyango ye-HER2-positive.
Umehluko omkhulu uvame ukuba yizindleko - ama-biosimilars afana ne-trastuzumab-dkst ngokuvamile abiza kancane kunomuthi wokuqala wegama lomkhiqizo. Lokhu kungenza ukwelashwa kufinyeleleke kalula futhi kunciphise izindleko zakho eziphuma ephaketheni.
Udokotela wakho angase akhethe enye ngaphezu kwenye ngokusekelwe ekuhlinzekweni komshwalense wakho, ukutholakala esikhungweni sakho sokwelashwa, noma okuthandayo. Zombili ziyizinketho ezinhle zokwelapha iminyango ye-HER2-positive.
I-Trastuzumab-dkst ingathinta ukusebenza kwenhliziyo, ngakho-ke abantu abanezinkinga zenhliziyo ezikhona badinga ukuqapha okwengeziwe. Udokotela wakho uzohlola impilo yenhliziyo yakho ngaphambi kokuqala ukwelashwa futhi aqhubeke nokuyihlola njalo.
Uma unezinkinga zenhliziyo ezilula, ungase ukwazi ukuthola lokhu kwelashwa ngokuqapha okuseduze. Kodwa-ke, abantu abanenhliziyo ehlulekayo enkulu noma ukusebenza kwenhliziyo okuncishiswe kakhulu ngokuvamile abakwazi ukuthola i-trastuzumab-dkst ngokuphepha.
Njengoba i-trastuzumab-dkst inikezwa ochwepheshe bezempilo endaweni yezokwelapha, ukweqisa ngengozi akunakwenzeka. Umuthi ulinganiswa ngokucophelela futhi unikezwa ngabanakekeli bezempilo nabadokotela abaqeqeshiwe.
Uma ukhathazekile ngomthamo wakho noma uhlangabezana nezimpawu ezingavamile ngemuva kokwelashwa, xhumana nethimba lakho lezempilo ngokushesha. Bangahlola isimo sakho futhi banikeze ukunakekelwa okufanele uma kudingeka.
Uma uphuthelwa ukufakwa okuhleliwe, xhumana nethimba lakho lezempilo ngokushesha ngangokunokwenzeka ukuze uhlele kabusha. Bazonquma isikhathi esingcono somthamo wakho olandelayo ngokusekelwe ukuthi sekunesikhathi esingakanani kusukela ekwelashweni kwakho kokugcina.
Ungazami ukuthi "ubambe" ngokuthola imithi eyengeziwe. Ithimba lakho lezokwelapha lizolungisa isimiso sakho ngokuphepha futhi liqinisekise ukuthi uhlala emgqeni nohlelo lwakho lokwelashwa.
Ungalokothi uyeke i-trastuzumab-dkst ngaphandle kokuxoxa ngayo nodokotela wakho we-oncologist kuqala. Isikhathi sincike esimweni sakho esithile nokuthi ukwelashwa kusebenza kahle kangakanani.
Ngesifo somdlavuza webele esigabeni sokuqala, ukwelashwa kuvame ukuthatha unyaka owodwa. Ngesifo somdlavuza esithuthukile, ungaqhubeka uma nje sisiza ukulawula umdlavuza wakho futhi ukubekezelela kahle. Udokotela wakho uzohlola njalo ukuthi uzoqhubeka yini, ulungise, noma uyeke ukwelashwa.
Ungathola imigomo eminingi ngenkathi uthatha i-trastuzumab-dkst, kodwa isikhathi nohlobo kubalulekile. Imigomo ephilayo (njengomuthi wokufutha umkhuhlane ngamakhala) kufanele igwenywe, kanti imigomo engasebenzi (njengomjovo womkhuhlane) ngokuvamile iphephile.
Xoxa nethimba lakho lezempilo ngaphambi kokuthola imigomo. Bangakunikeza iseluleko ngesikhathi esingcono kakhulu nokuthi yimiphi imigomo enconywayo ukukugcina uphilile ngesikhathi sokwelashwa.
6Mpeople
Get clear medical guidance
on symptoms, medications, and lab reports.